IBSA FARMACEUTICI ITALIA Srl

Discover IBSA PHARMACEUTICI ITALIA Srl: Italian pharmaceutical excellence

IBSA PHARMACEUTICI ITALIA Srl is a prominent company in the Italian pharmaceutical landscape, founded in 1992 with headquarters in Lodi. Part of the Institut Biochimique SA Group, the company stands out for its ability to combine scientific innovation, advanced technology, and attention to the individual. With over 630 employees and a revenue exceeding 350 million euros, IBSA is present in more than 90 countries worldwide, offering therapeutic solutions in various areas, including reproductive medicine, dermatology, endocrinology, orthopedics, and daily wellness.

Innovation and research in the service of health

IBSA places the person, their health, and well-being at the center of its operations. The company continually invests in research and development, using advanced technologies to optimize bioavailability, efficacy, and safety of active ingredients. Among its most significant innovations, IBSA has developed PEARLtec technology, which allows the incorporation of a liquid matrix into a continuous soft gel shell, improving the stability of the active ingredient and ensuring precise dosing.

Product range and recognitions

IBSA's portfolio includes a wide range of products, including pharmaceuticals, medical devices, and dietary supplements. Among its most well-known products are Flector, a topical treatment for joint and muscle pain, and Tirosint, a medication based on levothyroxine sodium for hypothyroidism therapy. Additionally, IBSA is a leader in aesthetic and regenerative medicine with the Viscoderm line and devices based on hyaluronic acid, such as Profhilo, symbolizing a new era in skin care.